Michael Merchlinsky - Concepedia

Author

Michael Merchlinsky

Center for Biologics Evaluation and Research

Also Known As

M J Merchlinsky, M Merchlinsky, Michael J. Merchlinsky, Michael Merchlinsky, Michael Merchlinsky (421357), Michael J. Merchlinsky

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Center for Biologics Evaluation and Research National Institute of Allergy and Infectious Diseases National Institutes of Health United States Food and Drug Administration Biomedical Advanced Research and Development Authority

About

Michael Merchlinsky is an author at Center for Biologics Evaluation and Research specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	28	1.5K
2	Natural Sciences	9	9	432
3	Allergy	2	2	66
4	Biochemistry	2	2	36
5	Biology	1	1	39

Michael Merchlinsky

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 Agam K. Rao, Brett W. Petersen, Florence Whitehill, MMWR Morbidity and Mortality Weekly Report	2022	413
Construction of an infectious molecular clone of the autonomous parvovirus minute virus of mice Michael Merchlinsky, Peter Tattersall, Jeffry J. Leary, Journal of Virology Virus StructureViral ReplicationMolecular VirologyPathogenesisInfectious Molecular Clone	1983	142
The complete DNA sequence of minute virus of mice, an autonomous parvovirus Caroline R. Astell, M. Scott Thomson, Michael Merchlinsky, Nucleic Acids Research	1983	141
Developing New Smallpox Vaccines Michael Merchlinsky, Cynthia Kleppinger, Karen L. Goldenthal Emerging infectious diseases VaccinationVaccinologyVeterinary VaccineVaccine DevelopmentNeurovirology	2001	138
DNA Packaging Mutant: Repression of the Vaccinia Virus A32 Gene Results in Noninfectious, DNA-Deficient, Spherical, Enveloped Particles M. Cristina Cassetti, Michael Merchlinsky, Elizabeth J. Wolffe, Journal of Virology Virus StructureViral ReplicationSynthetic VirologyNatural SciencesPathogenesis	1998	93
Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model Clement A. Meseda, Alonzo D. García, Arunima Kumar, Virology VaccinationVaccinologyVaccine DevelopmentImmunologySmallpox Vaccine Dryvax	2005	88
Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation: Recombination-independent selectable cloning vectors Michael Merchlinsky, Bernard Moss Virology Synthetic VirologyGeneticsGenetic EngineeringVirologyVaccinia Virus Genome	1992	84
Marker Rescue of the Host Range Restriction Defects of Modified Vaccinia Virus Ankara Linda S. Wyatt, Miles W. Carroll, Claus‐Peter Czerny, Virology VaccinationMarker RescueViral EvolutionPathogenesisImmunology	1998	75
Resolution of vaccinia virus DNA concatemer junctions requires late-gene expression Michael Merchlinsky, Bernard Moss Journal of Virology Viral ReplicationLate-gene ExpressionMolecular VirologyConcatemer ResolutionNatural Sciences	1989	73
CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus Montserrat Puig, Kathleen Mihalik, John C. Tilton, Hepatology Hepatitis C VirusImmunologyChimpanzee ImmunizationViral PersistenceViral Hepatitis	2006	72

Page 1